Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Status of the 'consensus nomenclature rules in radiopharmaceutical sciences' initiative.

Literature DB >> 31128474

Status of the 'consensus nomenclature rules in radiopharmaceutical sciences' initiative.

Heinz H Coenen¹, Antony D Gee², Michael Adam³, Gunnar Antoni⁴, Cathy S Cutler⁵, Yasuhisa Fujibayashi⁶, Jae Min Jeong⁷, Robert H Mach⁸, Thomas L Mindt⁹, Victor W Pike¹⁰, Albert D Windhorst¹¹.

Abstract

Mesh：

Substances：
Radiopharmaceuticals

Year: 2019 PMID： 31128474 DOI： 10.1016/j.nucmedbio.2019.05.001

Source DB: PubMed Journal: Nucl Med Biol ISSN： 0969-8051 Impact factor: 2.408

Keyword Cloud
Cited

× No keyword cloud information.

2 in total

1. A non-anhydrous, minimally basic protocol for the simplification of nucleophilic ¹⁸F-fluorination chemistry.

Authors: J A H Inkster; V Akurathi; A W Sromek; Y Chen; J L Neumeyer; A B Packard
Journal: Sci Rep Date: 2020-04-22 Impact factor: 4.379

2. Labeling single domain antibody fragments with ¹⁸F using a novel residualizing prosthetic agent - N-succinimidyl 3-(1-(2-(2-(2-(2-[¹⁸F]fluoroethoxy)ethoxy)ethoxy)ethyl)-1H-1,2,3-triazol-4-yl)-5-(guanidinomethyl)benzoate.

Authors: Zhengyuan Zhou; Darryl McDougald; Rebecca Meshaw; Irina Balyasnikova; Michael R Zalutsky; Ganesan Vaidyanathan
Journal: Nucl Med Biol Date: 2021-06-11 Impact factor: 2.947

2 in total

Status of the 'consensus nomenclature rules in radiopharmaceutical sciences' initiative.

1. A non-anhydrous, minimally basic protocol for the simplification of nucleophilic 18F-fluorination chemistry.

2. Labeling single domain antibody fragments with 18F using a novel residualizing prosthetic agent - N-succinimidyl 3-(1-(2-(2-(2-(2-[18F]fluoroethoxy)ethoxy)ethoxy)ethyl)-1H-1,2,3-triazol-4-yl)-5-(guanidinomethyl)benzoate.

1. A non-anhydrous, minimally basic protocol for the simplification of nucleophilic ¹⁸F-fluorination chemistry.

2. Labeling single domain antibody fragments with ¹⁸F using a novel residualizing prosthetic agent - N-succinimidyl 3-(1-(2-(2-(2-(2-[¹⁸F]fluoroethoxy)ethoxy)ethoxy)ethyl)-1H-1,2,3-triazol-4-yl)-5-(guanidinomethyl)benzoate.